Uzbekistan buys genetic drugs for children with spinal muscular atrophy
Uzbekistan buys genetic drugs for children with spinal muscular atrophy
The famous Swiss pharmaceutical company "Roche" and the representatives of the Ministry of Health discussed the implementation of the support program for children with spinal muscular atrophy and the prospects of cooperation in oncology.
Adriano Treve, head of the company for Central and Eastern Europe, Turkey, Russia, Indian subcontinent, Toylan Senel, head of the representative office in Kazakhstan, Anna Savinkina, representative in Albania, as well as Olgikh and Shokhida Sorbatti, partners of "Roche" in Uzbekistan attended at the meeting.
During the conversation, Minister Amrillo Inoyatov offered the organisation's representatives large-scale and long-term cooperation, including regional localisation of drugs produced by this company in the country.
Introducing biotechnology-based production into Uzbekistan will become a revolutionary event in the pharmaceutical industry. The company's experts say that several years of preparation and forming a solid material and technical base are necessary.
.jpg "X factor uzbekistan")
.png "YouTube UZREPORT TV")
